
This article reviews the clinical usefulness of three zzso zzso tumor zzso CA zzso or zzso CA 50, and CA zzso These markers have been regarded as worthwhile tools for diagnosis and monitoring the management of patients with zzso in selected zzso The CA zzso test in combination with the zzso test is a useful adjunct for staging in some advanced cases and for monitoring therapy in the majority of patients with zzso of the zzso zzso of these zzso performed zzso is comparable to zzso alone in zzso zzso The CA zzso test alone is useful for staging and monitoring management of patients with zzso of the zzso In zzso zzso the CA zzso test is redundant because of significantly lower sensitivity than that of the zzso zzso the latter remains the test of zzso The CA 50 test per zzso is redundant since the CA zzso zzso is the target for both the zzso zzso and the zzso zzso zzso The CA 125 test contributes to staging and is a useful adjunct for monitoring management of patients with zzso zzso of the zzso If positive after initial surgery and chemotherapy, this test provides evidence of the presence of residual or zzso tumor and thus may zzso the need for zzso zzso These conclusions are based on a review of recent relevant publications as well as on our own results obtained from zzso evaluation and zzso follow-up of about 600 patients with zzso in relevant zzso 

